Clinical Trials Browser

Phase 1/2 × Neoplasms × cabazitaxel × Clear all

NCT02202772 2025-02-24

CGC

Phase 1/2 Active not recruiting

Carcinoma, Neoplasms, Recurrence

NCT01001221 2013-09-11

Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor

Phase 1/2 Terminated

19 enrolled 55 charts

Neoplasms